GlassScriptPhysician profile
Rafeek Woods
NPI 1164712600
$1,269.77
in general payments reported to CMS, 2019-2025
12 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $165 · 2021: $122 · 2022: $111 · 2023: $138 · 2024: $233 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $333.71 | 2021-2025 | Mazor X System, Intellis Adaptivestim, Rialto Si Fusion System |
| Alphatec Spine, INC | $254.97 | 2024-2025 | Invictus Mis |
| Stryker Corporation | $230.54 | 2019-2025 | Prolift, N/A, Universal Neuro 3 |
| Depuy Synthes Sales INC. | $136.13 | 2019-2024 | Vertecem II |
| Si-Bone, INC. | $95.00 | 2021-2022 | |
| Medtronic USA, INC. | $60.65 | 2019-2020 | |
| Davol INC. | $60.34 | 2025 | Surgiphor |
| Heron Therapeutics, INC. | $24.25 | 2024 | Zynrelef |
| Nuvasive, INC. | $23.16 | 2019 | |
| Kuros Biosciences USA, INC | $22.87 | 2025 | Magnetos |
| Integra Lifesciences Corporation | $15.04 | 2019 | |
| Aesculap, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafeek Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.